Dynarex Corporation recalled 2,592 bottles of WeCare Zinc Oxide Ointment on October 31, 2025, due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers and healthcare providers must stop using the ointment immediately and seek guidance.
cGMP deviations
Consumers and healthcare providers should stop using this product immediately. Contact Blossom Pharmaceuticals or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
WeCare Zinc Oxide Ointment is a topical treatment typically used for skin irritations, rashes, and minor burns. Consumers often buy this product for its protective properties, particularly for infants and individuals with sensitive skin.
cGMP deviations indicate that the product may not have been manufactured to the required quality standards, potentially leading to contamination or ineffective treatment.
This recall is not part of a broader industry pattern.
The recall poses a high risk due to potential safety issues, prompting immediate action from consumers and healthcare providers.
Lot numbers and expiration dates are typically printed on the product packaging or label.
Expect a refund or replacement processing time of 4-6 weeks after returning the product.
Keep records of your purchase, including receipts and correspondence with the manufacturer for potential claims.
The recalled product is WeCare Zinc Oxide Ointment, net weight 15 oz (425 g). It was manufactured for Dynarex Corporation, located at 11 Dynarex Drive, Middletown, NY 10941. The affected lot numbers are A062434 and A062449, with expiration dates of June 27, 2027, and July 27, 2027.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
Dynarex Obstetrical Towelettes Cleanser is under an active FDA recall as of Jan. 20, 2026. The recall cites CGMP Deviations that could affect product quality. Consumers and healthcare providers should stop using the product immediately and contact ACME United Corporation or a healthcare provider for guidance.
Dynarex Corporation recalled 18,912 containers of Wecare Enema on October 31, 2025, due to cGMP deviations. Consumers should stop using the product immediately. The recall affects products distributed nationwide in the USA.
Dynashield, a 4 oz cream, is recalled after cGMP deviations were identified. The recall affects 7,944 units distributed nationwide. Consumers should stop using the product immediately and contact their healthcare provider for guidance.
Dyrnarex Corporation recalled 1,560 containers of Dynashield Skin Protectant on October 31, 2025. The product may not meet current Good Manufacturing Practice standards. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Dynarex Corporation recalled 2,400 containers of Wecare Calasoothe on October 31, 2025, due to cGMP deviations. The recall affects the 4 oz ointment, as it may not meet safety standards. Consumers should stop using the product immediately and consult their healthcare providers.